CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

Long-Term Outcomes Following Carotid Artery Stenting.

G New1*, G S Roubin1, S S Iyer1, N Al-Mubarak1, I Moussa1, G Yates2, M Liu2, J W Moses, J J Vitek1,

1Lenox Hill Heart and Vascular Institute, New York, New York, 2Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.

Background: Carotid stenting is a less invasive percutaneous procedure for the treatment of carotid artery stenosis. Many previous reports suggest that carotid stenting can be performed with similar peri-procedural complication rates compared with carotid endarterectomy. The study represents the largest prospective cohort of carotid stenting patients evaluated for acute and late-term outcomes.

Methods: Five-hundred and twenty-eight consecutive patients (604 hemispheres/vessels) undergoing elective CS were prospectively followed. There was 99.5% late follow-up in people eligible (n = 385, > 12 months, range: 12 to 55 months). Stroke and death rates were estimated at 30 days and at last follow-up (mean ± SD). Predictors of 30-day and late fatal and non-fatal stroke were identified.

Results: Procedural success rate was 98% (592/604). There was a 0.6% (n=3) fatal stroke rate and 1% (n=5) non-neurological death rate at 30 days. Major stroke rate was 1% (n=6) and the minor stroke rate was 4.8% (n=29). The overall thirty-day stroke and death rate was 7.4% (n=43). Over the 5 year study period, the 30-day stroke and death rate improved from 9.3% (n=9) for the first year to 4.3% (n=7) for the 5th year of the study (p<0.05 for trend). The most significant predictor of 30-day stroke and death was age >= 80 years, with this group having a stroke and death rate of 16% (n=12) compared with 6% (n=31) for patients < 80 years old (p < 0.01). On long-term follow-up there was an incremental 3.2% (n=31) incidence of fatal and non-fatal stroke beyond 30 days. Freedom from fatal and non-fatal stroke at 3 years was 88 ± 2%, and the freedom from ipsilateral non-fatal stroke and all fatal stroke was 92 ± 1%.

Conclusion: Experience from a single group of operators demonstrates that, carotid artery stenting can be performed with a 30-day peri-procedural complication rate similar to carotid endarterectomy. Late follow-up also demonstrates similar rates of fatal and non-fatal stroke compared with endarterectomy.

[ Back to 48th ASM Abstract Index ]


Med-E-Serv